Dmitry Kaminskiy, General Partner at Deep Knowledge Group, argues that FemTech represents far more than a consumer health vertical. It is the foundational infrastructure underpinning any serious national longevity strategy. Tracing the causal chain from preconception health through maternal outcomes to adult population resilience, Kaminskiy makes the case that without upstream investment in female biological health across the full lifecycle, longevity targets remain structurally unachievable.
Every nation that has successfully shaped its future has understood that the most decisive investments are rarely visible in the short term. They do not announce themselves through immediate returns or quarterly wins. They work silently, compounding across years, shaping generations before results become obvious.
Longevity belongs to this category of national ambition. And within it, FemTech is one of the least understood – but most powerful – forms of infrastructure a country can build.
A healthy biological demographic
FemTech is not merely about improving outcomes for women. It is about shaping the biological, demographic, and economic trajectory of entire societies. In the context of longevity, FemTech is more than a marginal healthcare vertical or a consumer wellness trend. It is foundational infrastructure. Any country serious about becoming a longevity-oriented nation must recognize this early. Otherwise, decades of avoidable health and economic fragility may ensue.
Consistent ‘production’ of healthier adults
Most healthcare systems today are optimized for short-term objectives. They are designed to treat disease, manage acute episodes, and control costs within electoral cycles. Longevity operates on a different timeline. It is a long-horizon project that requires generational thinking, systems design, and strategic patience. A longevity nation is not defined by how efficiently it treats illness in older age. It is defined by how consistently it produces healthier adults over time, reduces chronic disease before it accumulates, and preserves health-adjusted productivity across the population.
Once longevity is understood in these terms, the logic of intervention changes. If the objective is healthier adults at scale, the solution cannot begin in adulthood.
National longevity is best understood as a pipeline problem. Adult health outcomes are not random events that emerge in midlife. They are downstream results of biological, developmental, and environmental conditions established much earlier. Healthier adults emerge from healthier childhoods. Healthier childhoods depend on healthier pregnancies. Healthier pregnancies depend on maternal health. And maternal health during pregnancy is itself shaped by health long before conception occurs.
This causal chain is uncomfortable for systems built around reactive medicine, but it is unavoidable for anyone thinking seriously about population-level longevity. Once acknowledged, it leads to a clear conclusion: the longevity agenda must begin upstream, well before individuals enter the healthcare system as patients. This is precisely where FemTech becomes strategically decisive.
Healthier mothers, healthier children
Pregnancy represents one of the most critical biological windows in the human lifecycle. Maternal health during this period influences foetal development in ways that shape metabolic resilience, immune function, cognitive outcomes, and long-term disease risk. A nation that wants healthier children cannot ignore the health of mothers during pregnancy. Yet pregnancy itself is not a true starting point. It is an outcome of years of prior biological conditions.
Preconception health
Maternal health during pregnancy is strongly influenced by preconception health status. Nutritional reserves, metabolic balance, hormonal stability, mental health, and the management of chronic conditions all precede conception and directly affect pregnancy outcomes. This means that a credible national longevity strategy cannot begin with prenatal care alone. It must incorporate preconception health as a core domain of prevention, monitoring, and intervention.
‘Continuous health’
This is where FemTech fundamentally differs from traditional healthcare approaches. FemTech operates across the full female lifecycle, not only at moments of acute medical interaction. It enables continuous health insight, longitudinal data capture, prevention-oriented intervention, and earlier risk detection. In doing so, it addresses precisely the upstream determinants that shape population health decades later. This is not incremental optimization of women’s health services. It is systems engineering for national longevity.
Multi-generational longevity
The distinction between personal longevity and national longevity is critical. Personal longevity is largely an individual project, shaped by lifestyle choices, personal medical decisions, and individual risk management. National longevity is something else entirely. It is multi-generational by definition. It is systemic rather than individual. It requires policy alignment, institutional coordination, and long-term infrastructure investment. Aggregating individual wellness efforts will not produce a longevity nation. Strengthening upstream determinants of population health will.
Under this framing, FemTech is no longer optional, supplementary, or secondary. It becomes central. It shapes the biological starting conditions of future generations before healthcare systems ever begin to treat them. Countries that fail to integrate FemTech into their longevity strategies will find themselves managing ever-growing chronic disease burdens, rising healthcare costs, and declining healthspans. Countries that succeed will quietly compound advantages over decades, producing healthier adults, more resilient populations, and more stable economies.
Longevity nations are built upstream. And upstream, FemTech is indispensable.
